200 related articles for article (PubMed ID: 7879415)
1. Self-replicating Semliki Forest virus RNA as recombinant vaccine.
Zhou X; Berglund P; Rhodes G; Parker SE; Jondal M; Liljeström P
Vaccine; 1994 Dec; 12(16):1510-4. PubMed ID: 7879415
[TBL] [Abstract][Full Text] [Related]
2. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
Zhou X; Berglund P; Zhao H; Liljeström P; Jondal M
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3009-13. PubMed ID: 7708765
[TBL] [Abstract][Full Text] [Related]
3. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
Vignuzzi M; Gerbaud S; van der Werf S; Escriou N
J Gen Virol; 2001 Jul; 82(Pt 7):1737-1747. PubMed ID: 11413386
[TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice.
Berglund P; Fleeton MN; Smerdou C; Liljeström P
Vaccine; 1999 Feb; 17(5):497-507. PubMed ID: 10073729
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
[TBL] [Abstract][Full Text] [Related]
6. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
Huckriede A; Bungener L; Holtrop M; de Vries J; Waarts BL; Daemen T; Wilschut J
Vaccine; 2004 Mar; 22(9-10):1104-13. PubMed ID: 15003637
[TBL] [Abstract][Full Text] [Related]
8. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
Fleeton MN; Chen M; Berglund P; Rhodes G; Parker SE; Murphy M; Atkins GJ; Liljeström P
J Infect Dis; 2001 May; 183(9):1395-8. PubMed ID: 11294672
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunogenicity induced by an alphavirus replicon-based pseudotyped baculovirus vaccine against porcine reproductive and respiratory syndrome virus.
Wu Q; Xu F; Fang L; Xu J; Li B; Jiang Y; Chen H; Xiao S
J Virol Methods; 2013 Feb; 187(2):251-8. PubMed ID: 23201089
[TBL] [Abstract][Full Text] [Related]
10. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
[TBL] [Abstract][Full Text] [Related]
11. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
Fernández IM; Snijders A; Benaissa-Trouw BJ; Harmsen M; Snippe H; Kraaijeveld CA
J Virol; 1993 Oct; 67(10):5843-8. PubMed ID: 7690411
[TBL] [Abstract][Full Text] [Related]
12. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
Virology; 2000 Oct; 276(2):259-70. PubMed ID: 11040118
[TBL] [Abstract][Full Text] [Related]
13. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
[TBL] [Abstract][Full Text] [Related]
14. Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity.
Tannis LL; Gauthier A; Evelegh C; Parsons R; Nyholt D; Khromykh A; Bramson JL
Vaccine; 2005 Jul; 23(33):4189-94. PubMed ID: 16005737
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development.
Phenix KV; Wark K; Luke CJ; Skinner MA; Smyth JA; Mawhinney KA; Todd D
Vaccine; 2001 Apr; 19(23-24):3116-23. PubMed ID: 11312006
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.
Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Rice CM; Ling M; Wu TC
J Immunol; 2001 May; 166(10):6218-26. PubMed ID: 11342644
[TBL] [Abstract][Full Text] [Related]
17. Manipulation of the Semliki Forest virus genome and its potential for vaccine construction.
Atkins GJ; Sheahan BJ; Liljeström P
Mol Biotechnol; 1996 Feb; 5(1):33-8. PubMed ID: 8853014
[TBL] [Abstract][Full Text] [Related]
18. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
Sundbäck M; Douagi I; Dayaraj C; Forsell MN; Nordström EK; McInerney GM; Spångberg K; Tjäder L; Bonin E; Sundström M; Liljeström P; Karlsson Hedestam GB
Virology; 2005 Oct; 341(2):190-202. PubMed ID: 16098555
[TBL] [Abstract][Full Text] [Related]
19. Immune responses in mice vaccinated with a suicidal DNA vaccine expressing the hemagglutinin glycoprotein from the peste des petits ruminants virus.
Wang Y; Liu G; Shi L; Li W; Li C; Chen Z; Jin H; Xu B; Li G
J Virol Methods; 2013 Nov; 193(2):525-30. PubMed ID: 23896018
[TBL] [Abstract][Full Text] [Related]
20. Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.
Morris-Downes MM; Phenix KV; Smyth J; Sheahan BJ; Lileqvist S; Mooney DA; Liljeström P; Todd D; Atkins GJ
Vaccine; 2001 Feb; 19(15-16):1978-88. PubMed ID: 11228368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
